About Strongbridge Biopharma
Strongbridge Biopharma is a global, commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Cortendo AB is a Strongbridge Biopharma company and the sponsor of the LOGICS study. This means Cortendo AB planned and organized this study and will also collect and analyze the data from the study.
Want to Volunteer?
The safety and effectiveness of levoketoconazole for endogenous Cushing’s syndrome have not been established.